466 related articles for article (PubMed ID: 32720598)
1.
Li M; Sagastume EA; Lee D; McAlister D; DeGraffenreid AJ; Olewine KR; Graves S; Copping R; Mirzadeh S; Zimmerman BE; Larsen RH; Johnson FL; Schultz MK
Curr Med Chem; 2020; 27(41):7003-7031. PubMed ID: 32720598
[TBL] [Abstract][Full Text] [Related]
2. Automated cassette-based production of high specific activity [
Li M; Zhang X; Quinn TP; Lee D; Liu D; Kunkel F; Zimmerman BE; McAlister D; Olewein K; Menda Y; Mirzadeh S; Copping R; Johnson FL; Schultz MK
Appl Radiat Isot; 2017 Sep; 127():52-60. PubMed ID: 28521118
[TBL] [Abstract][Full Text] [Related]
3. Structural modifications toward improved lead-203/lead-212 peptide-based image-guided alpha-particle radiopharmaceutical therapies for neuroendocrine tumors.
Lee D; Li M; Liu D; Baumhover NJ; Sagastume EA; Marks BM; Rastogi P; Pigge FC; Menda Y; Johnson FL; Schultz MK
Eur J Nucl Med Mol Imaging; 2024 Mar; 51(4):1147-1162. PubMed ID: 37955792
[TBL] [Abstract][Full Text] [Related]
4. Preclinical Evaluation of
Banerjee SR; Minn I; Kumar V; Josefsson A; Lisok A; Brummet M; Chen J; Kiess AP; Baidoo K; Brayton C; Mease RC; Brechbiel M; Sgouros G; Hobbs RF; Pomper MG
J Nucl Med; 2020 Jan; 61(1):80-88. PubMed ID: 31253744
[TBL] [Abstract][Full Text] [Related]
5. Biological effect of lead-212 localized in the nucleus of mammalian cells: role of recoil energy in the radiotoxicity of internal alpha-particle emitters.
Azure MT; Archer RD; Sastry KS; Rao DV; Howell RW
Radiat Res; 1994 Nov; 140(2):276-83. PubMed ID: 7938477
[TBL] [Abstract][Full Text] [Related]
6. Towards translation of 212Pb as a clinical therapeutic; getting the lead in!
Yong K; Brechbiel MW
Dalton Trans; 2011 Jun; 40(23):6068-76. PubMed ID: 21380408
[TBL] [Abstract][Full Text] [Related]
7. In situ Generated
Stenberg VY; Juzeniene A; Bruland ØS; Larsen RH
Curr Radiopharm; 2020; 13(2):130-141. PubMed ID: 32389119
[TBL] [Abstract][Full Text] [Related]
8. A perspective on the radiopharmaceutical requirements for imaging and therapy of glioblastoma.
Bolcaen J; Kleynhans J; Nair S; Verhoeven J; Goethals I; Sathekge M; Vandevoorde C; Ebenhan T
Theranostics; 2021; 11(16):7911-7947. PubMed ID: 34335972
[TBL] [Abstract][Full Text] [Related]
9. Modeling Cell and Tumor-Metastasis Dosimetry with the Particle and Heavy Ion Transport Code System (PHITS) Software for Targeted Alpha-Particle Radionuclide Therapy.
Lee D; Li M; Bednarz B; Schultz MK
Radiat Res; 2018 Sep; 190(3):236-247. PubMed ID: 29944461
[TBL] [Abstract][Full Text] [Related]
10. Radionuclide spatial distribution and dose deposition for in vitro assessments of
Frelin-Labalme AM; Roger T; Falzone N; Quan Lee B; Sibson NR; Vallis KA; Bernaudin M; Valable S; Corroyer-Dulmont A
Med Phys; 2020 Mar; 47(3):1317-1326. PubMed ID: 31838744
[TBL] [Abstract][Full Text] [Related]
11. Targeted radionuclide therapy: frontiers in theranostics.
Gallivanone F; Valente M; Savi A; Canevari C; Castiglioni I
Front Biosci (Landmark Ed); 2017 Jun; 22(10):1750-1759. PubMed ID: 28410143
[TBL] [Abstract][Full Text] [Related]
12. Development and dosimetry of
Dos Santos JC; Schäfer M; Bauder-Wüst U; Lehnert W; Leotta K; Morgenstern A; Kopka K; Haberkorn U; Mier W; Kratochwil C
Eur J Nucl Med Mol Imaging; 2019 May; 46(5):1081-1091. PubMed ID: 30603987
[TBL] [Abstract][Full Text] [Related]
13. An improved generator for the production of 212Pb and 212Bi from 224Ra.
Atcher RW; Friedman AM; Hines JJ
Int J Rad Appl Instrum A; 1988; 39(4):283-6. PubMed ID: 2838433
[TBL] [Abstract][Full Text] [Related]
14. Pretargeted radioimmunotherapy in tumored mice using an in vivo 212Pb/212Bi generator.
Su FM; Beaumier P; Axworthy D; Atcher R; Fritzberg A
Nucl Med Biol; 2005 Oct; 32(7):741-7. PubMed ID: 16243650
[TBL] [Abstract][Full Text] [Related]
15. Solid-tumor radionuclide therapy dosimetry: new paradigms in view of tumor microenvironment and angiogenesis.
Zhu X; Palmer MR; Makrigiorgos GM; Kassis AI
Med Phys; 2010 Jun; 37(6):2974-84. PubMed ID: 20632610
[TBL] [Abstract][Full Text] [Related]
16. Targeted alpha therapy: part I.
Elgqvist J
Curr Radiopharm; 2011 Jul; 4(3):176. PubMed ID: 22201706
[TBL] [Abstract][Full Text] [Related]
17. Alpha Particle-Emitting Radiopharmaceuticals as Cancer Therapy: Biological Basis, Current Status, and Future Outlook for Therapeutics Discovery.
Coll RP; Bright SJ; Martinus DKJ; Georgiou DK; Sawakuchi GO; Manning HC
Mol Imaging Biol; 2023 Dec; 25(6):991-1019. PubMed ID: 37845582
[TBL] [Abstract][Full Text] [Related]
18. Comparison of short-lived high-LET alpha-emitting radionuclides lead-212 and bismuth-212 to low-LET X-rays on ovarian carcinoma.
Rotmensch J; Atcher RW; Hines J; Toohill M; Herbst AL
Gynecol Oncol; 1989 Dec; 35(3):297-300. PubMed ID: 2599463
[TBL] [Abstract][Full Text] [Related]
19. Implications of physics, chemistry and biology for dosimetry calculations using theranostic pairs.
Miller C; Rousseau J; Ramogida CF; Celler A; Rahmim A; Uribe CF
Theranostics; 2022; 12(1):232-259. PubMed ID: 34987643
[TBL] [Abstract][Full Text] [Related]
20. Dosimetry of [
Orcutt KD; Henry KE; Habjan C; Palmer K; Heimann J; Cupido JM; Gottumukkala V; Cissell DD; Lyon MC; Hussein AI; Liu D; Li M; Johnson FL; Schultz MK
Molecules; 2022 Sep; 27(18):. PubMed ID: 36144563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
